List of Tables
    Table 1. Gefitinib CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Gefitinib Market Trends
    Table 3. Gefitinib Market Drivers
    Table 4. Gefitinib Market Challenges
    Table 5. Gefitinib Market Restraints
    Table 6. Global Gefitinib Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Gefitinib Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Gefitinib Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Gefitinib Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Gefitinib Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Gefitinib Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Gefitinib Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Gefitinib Sales by Manufacturer, (K Pcs), 2017-2022
    Table 14. Global Gefitinib Sales Share by Manufacturer, 2017-2022
    Table 15. Global Gefitinib Price by Manufacturer (2017-2022) & (USD/Pcs)
    Table 16. Global Gefitinib Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Gefitinib by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gefitinib as of 2021)
    Table 18. Top Players of Gefitinib in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Gefitinib Product Type
    Table 20. Date of International Manufacturers Enter into Gefitinib Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Gefitinib Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Gefitinib Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Gefitinib Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Gefitinib Sales by Players, (K Pcs), 2020, 2021 & 2022
    Table 26. United States Gefitinib Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Gefitinib Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Gefitinib Sales in Volume by Region (2017-2022) & (K Pcs)
    Table 29. Global Gefitinib Sales in Volume Forecast by Region (2023-2028) & (K Pcs)
    Table 30. Global Gefitinib Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Gefitinib Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Gefitinib Sales in Volume by Country (2017-2028) & (K Pcs)
    Table 33. North America Gefitinib Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Gefitinib Sales in Volume by Region (2017-2028) & (K Pcs)
    Table 35. Asia Pacific Gefitinib Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Gefitinib Sales in Volume by Country (2017-2028) & (K Pcs)
    Table 37. Europe Gefitinib Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Gefitinib Sales in Volume by Country (2017-2028) & (K Pcs)
    Table 39. Latin Americaa Gefitinib Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Gefitinib Sales in Volume by Country (2017-2028) & (K Pcs)
    Table 41. Middle East and Africa Gefitinib Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. AstraZeneca Corporation Information
    Table 43. AstraZeneca Description and Business Overview
    Table 44. AstraZeneca Gefitinib Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 45. AstraZeneca Gefitinib Product
    Table 46. AstraZeneca Recent Development
    Table 47. Qilu Pharmaceutical Corporation Information
    Table 48. Qilu Pharmaceutical Description and Business Overview
    Table 49. Qilu Pharmaceutical Gefitinib Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 50. Qilu Pharmaceutical Product
    Table 51. Qilu Pharmaceutical Recent Development
    Table 52. Natco Pharma Corporation Information
    Table 53. Natco Pharma Description and Business Overview
    Table 54. Natco Pharma Gefitinib Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 55. Natco Pharma Product
    Table 56. Natco Pharma Recent Development
    Table 57. Celon Laboratories Corporation Information
    Table 58. Celon Laboratories Description and Business Overview
    Table 59. Celon Laboratories Gefitinib Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 60. Celon Laboratories Product
    Table 61. Celon Laboratories Recent Development
    Table 62. Hetero Drugs Corporation Information
    Table 63. Hetero Drugs Description and Business Overview
    Table 64. Hetero Drugs Gefitinib Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 65. Hetero Drugs Product
    Table 66. Hetero Drugs Recent Development
    Table 67. Dr Reddy's Laboratories Corporation Information
    Table 68. Dr Reddy's Laboratories Description and Business Overview
    Table 69. Dr Reddy's Laboratories Gefitinib Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 70. Dr Reddy's Laboratories Product
    Table 71. Dr Reddy's Laboratories Recent Development
    Table 72. Zuventus Healthcare Corporation Information
    Table 73. Zuventus Healthcare Description and Business Overview
    Table 74. Zuventus Healthcare Gefitinib Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 75. Zuventus Healthcare Product
    Table 76. Zuventus Healthcare Recent Development
    Table 77. United Biotech Corporation Information
    Table 78. United Biotech Description and Business Overview
    Table 79. United Biotech Gefitinib Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 80. United Biotech Product
    Table 81. United Biotech Recent Development
    Table 82. Panacea Biotec Corporation Information
    Table 83. Panacea Biotec Description and Business Overview
    Table 84. Panacea Biotec Gefitinib Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 85. Panacea Biotec Product
    Table 86. Panacea Biotec Recent Development
    Table 87. Cipla Corporation Information
    Table 88. Cipla Description and Business Overview
    Table 89. Cipla Gefitinib Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 90. Cipla Product
    Table 91. Cipla Recent Development
    Table 92. Glenmark Pharmaceuticals Corporation Information
    Table 93. Glenmark Pharmaceuticals Description and Business Overview
    Table 94. Glenmark Pharmaceuticals Gefitinib Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 95. Glenmark Pharmaceuticals Product
    Table 96. Glenmark Pharmaceuticals Recent Development
    Table 97. Nobel Ilac Sanayii Ve Ticaret Corporation Information
    Table 98. Nobel Ilac Sanayii Ve Ticaret Description and Business Overview
    Table 99. Nobel Ilac Sanayii Ve Ticaret Gefitinib Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 100. Nobel Ilac Sanayii Ve Ticaret Product
    Table 101. Nobel Ilac Sanayii Ve Ticaret Recent Development
    Table 102. Accure Labs Corporation Information
    Table 103. Accure Labs Description and Business Overview
    Table 104. Accure Labs Gefitinib Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 105. Accure Labs Product
    Table 106. Accure Labs Recent Development
    Table 107. Cadila Pharmaceuticals Corporation Information
    Table 108. Cadila Pharmaceuticals Description and Business Overview
    Table 109. Cadila Pharmaceuticals Gefitinib Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 110. Cadila Pharmaceuticals Product
    Table 111. Cadila Pharmaceuticals Recent Development
    Table 112. Ethypharm Corporation Information
    Table 113. Ethypharm Description and Business Overview
    Table 114. Ethypharm Gefitinib Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 115. Ethypharm Product
    Table 116. Ethypharm Recent Development
    Table 117. Flagship Biotech International Corporation Information
    Table 118. Flagship Biotech International Description and Business Overview
    Table 119. Flagship Biotech International Gefitinib Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 120. Flagship Biotech International Product
    Table 121. Flagship Biotech International Recent Development
    Table 122. Globela Pharma Corporation Information
    Table 123. Globela Pharma Description and Business Overview
    Table 124. Globela Pharma Gefitinib Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 125. Globela Pharma Product
    Table 126. Globela Pharma Recent Development
    Table 127. Jodas Expoim Corporation Information
    Table 128. Jodas Expoim Description and Business Overview
    Table 129. Jodas Expoim Gefitinib Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 130. Jodas Expoim Product
    Table 131. Jodas Expoim Recent Development
    Table 132. Nishchay Pharmaceuticals Corporation Information
    Table 133. Nishchay Pharmaceuticals Description and Business Overview
    Table 134. Nishchay Pharmaceuticals Gefitinib Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 135. Nishchay Pharmaceuticals Product
    Table 136. Nishchay Pharmaceuticals Recent Development
    Table 137. Sichuan Xieli Pharmaceutical Corporation Information
    Table 138. Sichuan Xieli Pharmaceutical Description and Business Overview
    Table 139. Sichuan Xieli Pharmaceutical Gefitinib Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 140. Sichuan Xieli Pharmaceutical Product
    Table 141. Sichuan Xieli Pharmaceutical Recent Development
    Table 142. Key Raw Materials Lists
    Table 143. Raw Materials Key Suppliers Lists
    Table 144. Gefitinib Customers List
    Table 145. Gefitinib Distributors List
    Table 146. Research Programs/Design for This Report
    Table 147. Key Data Information from Secondary Sources
    Table 148. Key Data Information from Primary Sources
List of Figures
    Figure 1. Gefitinib Product Picture
    Figure 2. Global Gefitinib Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Gefitinib Market Size 2017-2028 (US$ Million)
    Figure 4. Global Gefitinib Sales 2017-2028 (K Pcs)
    Figure 5. United States Gefitinib Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Gefitinib Market Size 2017-2028 (US$ Million)
    Figure 7. United States Gefitinib Sales 2017-2028 (K Pcs)
    Figure 8. United States Gefitinib Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Gefitinib Market Share in Global, in Volume (K Pcs) 2017-2028
    Figure 10. Gefitinib Report Years Considered
    Figure 11. Product Picture of 10 Tables/Box
    Figure 12. Product Picture of 30 Tables/Box
    Figure 13. Product Picture of 90 Tables/Box
    Figure 14. Global Gefitinib Market Share by Type in 2022 & 2028
    Figure 15. Global Gefitinib Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 16. Global Gefitinib Sales Market Share in Value by Type (2017-2028)
    Figure 17. Global Gefitinib Sales by Type (2017-2028) & (K Pcs)
    Figure 18. Global Gefitinib Sales Market Share in Volume by Type (2017-2028)
    Figure 19. Global Gefitinib Price by Type (2017-2028) & (USD/Pcs)
    Figure 20. United States Gefitinib Market Share by Type in 2022 & 2028
    Figure 21. United States Gefitinib Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 22. United States Gefitinib Sales Market Share in Value by Type (2017-2028)
    Figure 23. United States Gefitinib Sales by Type (2017-2028) & (K Pcs)
    Figure 24. United States Gefitinib Sales Market Share in Volume by Type (2017-2028)
    Figure 25. United States Gefitinib Price by Type (2017-2028) & (USD/Pcs)
    Figure 26. Product Picture of Hospital
    Figure 27. Product Picture of Clinic
    Figure 28. Product Picture of Drug Center
    Figure 29. Product Picture of Other
    Figure 30. Global Gefitinib Market Share by Application in 2022 & 2028
    Figure 31. Global Gefitinib Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 32. Global Gefitinib Sales Market Share in Value by Application (2017-2028)
    Figure 33. Global Gefitinib Sales by Application (2017-2028) & (K Pcs)
    Figure 34. Global Gefitinib Sales Market Share in Volume by Application (2017-2028)
    Figure 35. Global Gefitinib Price by Application (2017-2028) & (USD/Pcs)
    Figure 36. United States Gefitinib Market Share by Application in 2022 & 2028
    Figure 37. United States Gefitinib Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 38. United States Gefitinib Sales Market Share in Value by Application (2017-2028)
    Figure 39. United States Gefitinib Sales by Application (2017-2028) & (K Pcs)
    Figure 40. United States Gefitinib Sales Market Share in Volume by Application (2017-2028)
    Figure 41. United States Gefitinib Price by Application (2017-2028) & (USD/Pcs)
    Figure 42. North America Gefitinib Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 43. North America Gefitinib Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 44. U.S. Gefitinib Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Canada Gefitinib Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 46. Europe Gefitinib Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 47. Europe Gefitinib Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 48. Germany Gefitinib Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 49. France Gefitinib Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 50. U.K. Gefitinib Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Italy Gefitinib Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Russia Gefitinib Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 53. Asia-Pacific Gefitinib Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 54. Asia-Pacific Gefitinib Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 55. China Gefitinib Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 56. Japan Gefitinib Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 57. South Korea Gefitinib Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 58. India Gefitinib Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. Australia Gefitinib Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. Taiwan Gefitinib Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. Indonesia Gefitinib Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. Thailand Gefitinib Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 63. Malaysia Gefitinib Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 64. Philippines Gefitinib Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 65. Latin America Gefitinib Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 66. Latin America Gefitinib Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 67. Mexico Gefitinib Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 68. Brazil Gefitinib Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 69. Argentina Gefitinib Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 70. Middle East & Africa Gefitinib Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 71. Middle East & Africa Gefitinib Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 72. Turkey Gefitinib Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 73. Saudi Arabia Gefitinib Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 74. U.A.E Gefitinib Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 75. Gefitinib Value Chain
    Figure 76. Gefitinib Production Process
    Figure 77. Channels of Distribution
    Figure 78. Distributors Profiles
    Figure 79. Bottom-up and Top-down Approaches for This Report
    Figure 80. Data Triangulation
    Figure 81. Key Executives Interviewed